Our Vision
We aim to find innovative therapeutic approaches and diagnostic methods to better overcome challenges encountered in clinical practice. These approaches will be based on thorough and comprehensive investigation of biologic and molecular processes in head and neck cancer targeting and siRNA-based gene silencing This is done via exosomes and lipid-based nanpoparticles (LNPs) as endogenous and synthetic (respectively) delivery systems. (exosomes or LNPs) targeting toward cancer cells for therapeutic, diagnostics and other applications. more specifically CAF’s, in order to examine the relationship between cancer cells and fibroblasts, for the prevention of key steps in cancer growth. (EV’s) of human embryonic stem cells (hESC), in hope to harness them as a therapeutic delivery tool. The lab is using cutting edge molecular tools and technologies to examine the genetic signature of recurrent disease. to detect cancer circDNA Designing novel molecular tools to detect cancer circDNA in blood samples and saliva (“liquid biopsy”) before any physical signs appears. These tools will also be used to monitor cancer recurrence or metastases Highlight Publications
Our Team
Research
.
